Insider Transactions Reported by 18 Insiders of Athira Pharma, Inc.

Symbol
ATHA on Nasdaq
Location
Bothell, WA

Insiders trading volume in the past year

Athira Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PERCEPTIVE ADVISORS LLC Director, 10%+ Owner $17,718,931 23 Dec 2025
Mark James Litton President and CEO, Director $414,442 -$25,165 -5.7% 31 Dec 2025
HANS MOEBIUS Chief Medical Officer $266,213 04 Jan 2024
Kelly A. Romano Director $194,951 30 May 2025
KEVIN CHURCH Chief Scientific Officer $175,192 -$8,529 -4.6% 31 Dec 2025
Mark Worthington General Counsel and CCO $128,344 -$8,529 -6.2% 31 Dec 2025
Javier San Chief Medical Officer $111,782 -$14,493 -11% 31 Dec 2025
Robert Renninger Chief Financial Officer $110,370 -$2,894 -2.6% 31 Dec 2025
Andrew Gengos CFO and Chief Business Officer $55,203 03 Sep 2024
Rachel Lenington COO and CDO $11,812 03 Sep 2024
GLENNA MILESON Chief Financial Officer 19 Jan 2023
JOHN M. FLUKE JR Director 30 May 2025
JAMES A. JOHNSON Director 30 May 2025
Tadataka Yamada Director 28 May 2021
GRANT PICKERING Director 30 May 2025
Barbara Kosacz Director 30 May 2025
JOSEPH EDELMAN Director 30 May 2025
Michael A. Panzara Director 30 May 2025

Recent Insider Transactions by Companies or Individuals for Athira Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.